CIK 0001677077 · <br>Emerging growth company
Alzamend Neuro, Inc.
Sign in to watch- Ticker
- ALZN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811822909
- Phone
- 844-722-6333
- Business address
- 480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,116
- in 1 filing
Net −$3,116. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-28 | AULT MILTON C III 10% owner | Purchase | +1,800 | $10.12 | $18K | 5,264,655 |
| 2021-06-28 | AULT MILTON C III 10% owner | Purchase | +400 | $11.40 | $5K | 5,265,055 |
| 2021-06-25 | AULT MILTON C III 10% owner | Purchase | +14,000 | $8.79 | $123K | 5,256,055 |
| 2021-06-24 | AULT MILTON C III 10% owner | Purchase | +9,500 | $8.24 | $78K | 5,242,055 |
| 2021-06-23 | AULT MILTON C III 10% owner | Purchase | +2,500 | $8.96 | $22K | 5,232,555 |
| 2021-06-22 | AULT MILTON C III 10% owner | Purchase | +22,000 | $7.73 | $170K | 5,230,055 |
| 2021-06-21 | AULT MILTON C III 10% owner | Purchase | +6,500 | $8.10 | $53K | 5,208,055 |
| 2021-06-18 | AULT MILTON C III 10% owner | Purchase | +16,500 | $9.28 | $153K | 5,202,055 |
| 2021-06-18 | AULT MILTON C III 10% owner | Sale | −500 | $9.52 | $5K | 5,201,555 |
| 2021-06-17 | AULT MILTON C III 10% owner | Purchase | +16,500 | $10.51 | $173K | 5,186,055 |
| 2021-06-17 | AULT MILTON C III 10% owner | Sale | −500 | $10.80 | $5K | 5,185,555 |
| 2021-06-17 | AULT MILTON C III 10% owner | Conversion | +15,000,000 | 15,000,000 | ||
| 2021-06-17 | AULT MILTON C III 10% owner | Conversion · Series A Convertible Preferred Stock | −750,000 | 0 | ||
| 2021-06-16 | AULT MILTON C III 10% owner | Purchase | +11,100 | $10.81 | $120K | 5,169,555 |
| 2021-06-15 | GUSTAFSON MARK Director | Grant or award · Restricted Stock Grant | +100,000 | 100,000 | ||
| 2021-06-15 | GUSTAFSON MARK Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2021-06-15 | McGrath Lynne Fahey Director | Grant or award · Restricted Stock Grant | +100,000 | 100,000 | ||
| 2021-06-15 | McGrath Lynne Fahey Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2021-06-15 | Oram Jeffrey Director | Grant or award · Restricted Stock Grant | +100,000 | 100,000 | ||
| 2021-06-15 | Oram Jeffrey Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 |
Page 14 of 15 · 284 trades